Treatment of atopic dermatitis with herbal combination of Eleutherococcus, Achillea millefolium, and Lamium album has no advantage over placebo: A double blind, placebo-controlled, randomized trial - 21/08/11
Doi : 10.1016/j.jaad.2003.05.008
Michael Y. Shapira, MD a, ⁎ 
, Yisrael Raphaelovich, MD d, Leon Gilad, MD, PhD b, Reuven Or, MD a, Avraham J. Dumb, PhD c, Arieh Ingber, MD b
, Yisrael Raphaelovich, MD d, Leon Gilad, MD, PhD b, Reuven Or, MD a, Avraham J. Dumb, PhD c, Arieh Ingber, MD b a From the Departments of Bone Marrow Transplantation
b Dermatology, Hadassah University Hospital
c Department of Medicinal Chemistry and Natural Products, School of Pharmacy
d The Hebrew University-Hadassah Medical School; and Raphael Natural Products
Correspondence to: Michael Y. Shapira, MD, Department of Bone Marrow Transplantation, Hadassah University Hospital, PO Box 12000, Jerusalem, Israel 91120.Jerusalem, Israel
Abstract |
Objective |
To test the efficacy of tri-herbal combination on atopic dermatitis in a randomized, placebo-controlled trial.
Methods |
Forty-nine patients were included for 2 weeks of treatment. Patients were followed until week 8.
Results |
The response to the real medication was significant in objective and subjective parameters. Patients maintained partial remission until the end of follow-up. The placebo-treated group had a similar response without a significant difference.
Conclusions |
Treatment with tri-herbal combination for atopic dermatitis does not differ from treatment with placebo.
Le texte complet de cet article est disponible en PDF.Plan
| Supported by Raphael Natural Products. Conflicts of interest: None identified. |
© 2005
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 52 - N° 4
P. 691-693 - avril 2005 Retour au numéro
Article précédent
- March iotaderma (#134)
- Robert I. Rudolph
- Papular mycosis fungoides: A new clinical variant of early mycosis fungoides
- Kazuo Kodama, Regina Fink-Puches, Cesare Massone, Helmut Kerl, Lorenzo Cerroni
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?